Phase 3 Respiratory distress syndrome Clinical Trials
18 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–18 of 18 trials
Recruiting
Phase 3
Pirfenidone to Prevent Fibrosis in Ards.
Acute Respiratory Distress Syndrome (ARDS)
Università Vita-Salute San Raffaele130 enrolled17 locationsNCT05075161
Recruiting
Phase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Respiratory distress syndromePre-term Infants
Aerogen Pharma Limited520 enrolled12 locationsNCT06776783
Recruiting
Phase 3
"Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"
Acute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation Complication
Assistance Publique - Hôpitaux de Paris280 enrolled11 locationsNCT06814340
Recruiting
Phase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
ARDSAcute Respiratory Distress Syndrome
Direct Biologics, LLC970 enrolled32 locationsNCT05354141
Recruiting
Phase 2Phase 3
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Acute Respiratory Distress Syndrome (ARDS)Acute Lung Injury(ALI)Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine60 enrolled1 locationNCT07342205
Recruiting
Phase 3
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome (ARDS)
Staidson (Beijing) Biopharmaceuticals Co., Ltd406 enrolled15 locationsNCT07208591
Recruiting
Phase 2Phase 3
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
Nonintubated Acute Respiratory Distress Syndrome (ARDS)Pathogen-associated Lung Injury
Bentley J. Bobrow1,100 enrolled1 locationNCT07086755
Recruiting
Phase 3
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
Multiple traumaRespiratory Distress Syndrome, Adult
University Hospital, Strasbourg, France500 enrolled1 locationNCT03368092
Recruiting
Phase 3
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Respiratory FailureAcute Respiratory Distress Syndrome
Beth Israel Deaconess Medical Center1,100 enrolled24 locationsNCT06066502
Recruiting
Phase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
Intubation ComplicationRespiratory Distress Syndrome (Neonatal)Death; Neonatal
ONY220 enrolled10 locationsNCT05960929
Recruiting
Phase 3
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Acute Respiratory Distress Syndrome (ARDS)
Consorcio Centro de Investigación Biomédica en Red (CIBER)350 enrolled10 locationsNCT05847517
Recruiting
Phase 2Phase 3
A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Fayoum University300 enrolled1 locationNCT06496997
Recruiting
Phase 3
Inhaled Sevoflurane for ARDS Prevention
Acute Respiratory Distress Syndrome
University Hospital, Clermont-Ferrand80 enrolled1 locationNCT05849779
Recruiting
Phase 3
Effect of Esmolol on Oxygenation Index in Patients With Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Zhiming Jiang178 enrolled1 locationNCT06013319
Recruiting
Phase 3
The C*STEROID Trial: Corticosteroids before planned caesarean section from 35+0 to 39+6 weeks of pregnancy.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
The University of Auckland2,548 enrolled23 locationsACTRN12620000914965
Terminated
Phase 3
The C*STEROID Feasibility Study: a two-site, randomised placebo controlled trial of corticosteroids before planned caesarean section delivery at 35+0 to 39+6 weeks of pregnancy to determine feasibility for recruitment to the C*STEROID Trial.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
University of Auckland400 enrolled1 locationACTRN12618002028280
Active
Phase 3
Preventing Lung Disease Using Surfactant + Steroid (The PLUSS Trial)
Extremely preterm birthRespiratory distress syndrome
The Melbourne Children's Trial Centre1,060 enrolled18 locationsACTRN12617000322336
Terminated
Phase 2Phase 3
Aerosolized surfactant in the first hour of life
Infant Respiratory Distress Syndrome
School of Women’s and Infants’ Health (SWIH)110 enrolled1 locationACTRN12610000857000